NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)

The NHLBI Emerging Investigator Award (EIA) is a grant intended to encourage and support in-depth research in the fields of heart, lung, blood, and sleep (HLBS). Designed for experienced Principal Investigators (PIs) with at least two current NHLBI R01-equivalent awards, the EIA grant provides long-term financial support and increased flexibility.

This award differs from others in that it supports an entire research program rather than a single research project. As the primary, and possibly exclusive, source of NHLBI funding on individual grants, the EIA is dedicated to fostering innovation and productivity in the scientific field. It does so by enabling researchers to conduct groundbreaking studies or to take their previous findings in new, exploratory directions.

Recipients of the EIA are encouraged to take scientific risks and conduct their research over an extended timeframe. This award extends to a period of up to seven years, affording ample time to delve deeply into HLBS research. However, it's crucial that the scope of their research aligns with the NHLBI's mission. More details regarding the mission can be found on the NHLBI website.